Korea-based Medison is hoping to expand its share of the U.S. ultrasound market with systems that offer color digital imaging capability and high-end live 3D rendering of fetal and organ movements. Carrying the load for these aspirations are SonoAce
Korea-based Medison is hoping to expand its share of the U.S. ultrasound market with systems that offer color digital imaging capability and high-end live 3D rendering of fetal and organ movements. Carrying the load for these aspirations are SonoAce Pico, which is being targeted to private-practice obstetricians and gynecologists, internists, radiologists, emergency departments, and small breast-imaging centers, and flagship Accuvix XQ for routine 2D studies and high-resolution and live 3D scans. (Prototypes of the two systems were unveiled at the 2002 RSNA meeting.)
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.